Myers Michael
CIK 0001959547
Chief Executive OfficerDirector
Filings
7
Latest Feb 6, 2026
Issuers covered
1
Showing
7 of 7
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 20% | -26.8% | -39.5% | +13.0% | -39.5% |
| 90 days | 5 | 60% | -8.5% | +2.4% | +2.4% | -43.3% |
| 180 days | 5 | 0% | -59.0% | -62.1% | -53.0% | -62.1% |
| 365 days | 5 | 0% | -62.5% | -72.8% | -26.9% | -72.8% |
Issuers
Companies where Myers Michael has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| QNRX | Quoin Pharmaceuticals, Ltd. | 7 | Feb 6, 2026 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|